PHYSICIANS
Learn how the SPRINT PNS System can help you treat patients suffering from acute and chronic pain without drugs, implants, anesthesia, or incisions.
PATIENTS
Whether you're dealing with chronic pain or acute post surgical pain, the SPRINT PNS System is designed to offer sustained, significant non-opiate pain relief.
SPRINT PNS SYSTEM
SPRINT is the only FDA cleared percutaneous peripheral nerve stimulation system specifically designed for use in the periphery that preferentially activates target nerve fibers, delivering sustained, significant pain relief without opiates, permanent implants, or tissue destruction.
NEWS & EVENTS
August 16, 2018
FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management
November 9, 2017
Opioid abuse is one of America’s top public health problems. But these companies have new ways to help.
September 12, 2017
SPR Therapeutics® Secures $25 Million in Series C Financing
September 7, 2017
SPR Therapeutics Promotes Dr. Joseph Boggs to SVP of Research and Development
August 14, 2017
Patient Factors Affecting Surgeon Selection and the Decision to Delay Total Knee Arthroplasty
August 3, 2017
Opioid Concerns and Work Interference Cited as Top Reasons to Delay Knee Replacement Surgery
March 21, 2017
SPR Therapeutics Appoints Michael P. Chuisano to Board of Directors
January 17, 2017
SPR Therapeutics Names Dave Youngberg Vice President of Sales
January 5, 2017
Fighting opioid addiction with new tech devices to treat chronic pain
October 24, 2016
Veterans Affairs Appoints Dr. Joseph Boggs to Advisory Board
October 5, 2016
Neurostimulation Emerges as an Alternative to Opioids
October 3, 2016
SPR’s Sprint System is the topic of a “Daring Discourse” in the November issue of Regional Anesthesia and Pain Medicine